Abilita
Abilita Bio is a private biotechnology company focused on leveraging its proprietary EMP membrane protein stabilization technologies to become the leader in discovering and developing transformative antibody therapeutics for the most medically important, yet challenging, drug targets, such as G protein-coupled receptors (GPCRs), transporters and ion channels.
Contact Name:
Mauro Mileni
Contact Email:
Website:
https://www.abilitabio.com
City, State – Congressional District:
San Diego,
CA
–
51
Technology:
Drug
Funding:
Cancer (NCI),
Drug Abuse (NIDA),
Aging (NIA)
NIH Projects:
NIH RePorter for
Abilita
Sponsored Event(s):
BIO | 2021
